Is Dentsply Sirona Inc (XRAY) overvalued? · rev $3.68B
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
This page asks whether Dentsply Sirona Inc (XRAY) looks expensive on cached numbers — not a short thesis.
Latest reported XRAY revenue for 2025-12-31 was $3.68B. Net income was -$598.0M. Revenue was down 3.0% from 2024-12-31 to 2025-12-31. XRAY currently screens at market cap $2.01B.
XRAY currently screens at market cap $2.01B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next XRAY 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the XRAY stock page for the full model, not this heading.
Not investment advice.